Literature DB >> 21318218

Anti-adult T-cell leukemia effects of Bidens pilosa.

Shinji Nakama1, Chie Ishikawa, Sawako Nakachi, Naoki Mori.   

Abstract

We evaluated the effects of Bidens pilosa, a plant found in tropical and subtropical regions, and investigated the molecular pathways responsible for the anti-adult T-cell leukemia (ATL) effect. Water extracts of B. pilosa had growth suppressive effects on human T-cell leukemia virus type 1 (HTLV-1)-infected T-cell lines and ATL cells. B. pilosa extracts arrested cells in G1 cell cycle and induced apoptosis of HTLV-1-infected T-cell lines. B. pilosa extracts inhibited also the phosphorylation of IκB kinase β and IκBα, and NF-κB-DNA binding, in conjunction with reduction of expression of proteins involved in G1/S cell cycle transition and suppression of apoptosis. Reactive oxygen species played a role in B. pilosa-mediated suppression of NF-κB activity. B. pilosa extracts also inhibited the expression of JunB and JunD, resulting in suppression of AP-1-DNA binding. In animals harboring tumors of HTLV-1-infected T-cell origin, treatment with B. pilosa extracts suppressed tumor growth. Our results suggest that B. pilosa is a potentially useful medicinal plant for treatment of ATL.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21318218     DOI: 10.3892/ijo.2011.939

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  2 in total

1.  In vitro effects and mechanisms of action of Bidens pilosa in Trypanosoma brucei.

Authors:  Aboagye Kwarteng Dofuor; Georgina Isabella Djameh; Michael Amoa-Bosompem; Samuel Kwain; Enoch Osei; Gilbert Mawuli Tetevi; Frederick Ayertey; Peter Bolah; Laud Kenneth Okine; Kwaku Kyeremeh; Theresa Manful Gwira; Mitsuko Ohashi
Journal:  J Tradit Complement Med       Date:  2021-08-11

2.  Bidens pilosa Extract Administered after Symptom Onset Attenuates Glial Activation, Improves Motor Performance, and Prolongs Survival in a Mouse Model of Amyotrophic Lateral Sclerosis.

Authors:  Yasuhiro Kosuge; Erina Kaneko; Hiroshi Nango; Hiroko Miyagishi; Kumiko Ishige; Yoshihisa Ito
Journal:  Oxid Med Cell Longev       Date:  2020-01-29       Impact factor: 6.543

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.